PHYLLIS RUMORE-FARRIS: Open Payments
NPI 1437140738 · CALIFORNIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 33 payments from 22 companies in 2025. Trend: 2023 $964 · 2024 $858 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $80 |
| Janssen Biotech, Inc. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $62 |
| Pharmacosmos Therapeutics Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Karyopharm Therapeutics Inc. | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| pharmaand GmbH | 1 | $27 |
Products named: Padcev, LIBTAYO, LifeVest, TECVAYLI, MONOFERRIC, XPOVIO, Nubeqa, Rubraca.
Industry payments across MD — which companies pay providers there.
